摘要
乌头类中药是一类常用中药材,含有多种生物活性物质,具有很高的药用价值,然而毒性极强,其主要毒性成分是乌头碱、新乌头碱、次乌头碱,同时也是有效成分,因此临床使用的安全性应受到广泛关注。随着药物开发研究的不断深入,人们已经不满足于仅仅了解药物的毒性,更迫切地需要了解其致毒机制及毒性产生和发展的规律性,以便对药物的安全性作出科学合理的评价,因此毒代动力学及代谢组学评价已逐渐成为创新药物评价的一项重要内容。建立科学、客观、规范的乌头类中药安全评估体系,正确评估和运用其毒性,是药物性能开发的重要内容。作者通过近年来对乌头类药物的毒代动力学和代谢组学研究进展进行综述,提出加强乌头类药物安全性评价研究工作,尽快建立科学,规范的安全评价体系,使民族瑰宝发挥出更大的优势。
Aconitum, as a kind of common traditional Chinese medicine, contains muhiple biological active substances, with a very high medicinal value but high toxicity. Its major toxic ingredients are aconitine, mesaconitine and hypaconitine, which are also efficient ingredients. Therefore, the safety of its clinical application has aroused wide attention. With the constant deepening of drug development studies, people want to learn about its toxic mechanism and the regularity of its emergence and development of its toxicology, so as to make a scientific and rational assessment for its safety. Therefore, toxicokinetics and metabonomics have gradually become im- portant content in the new drug assessment. During the development of drug performance, it is crucial to establish a scientific, objective and standardized Aconitum safety evaluation system and correctly assess and utilize its toxicity. Having summarized studies on metabonomics and toxicokinetics of Aconitum drugs in recent years, authors proposed to strengthen the studies on Aconitum drug safety assessment and establish a scientific and standardized safety evaluation system as soon as possible, in order to make the national treas- ure more useful.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2014年第11期1972-1975,共4页
China Journal of Chinese Materia Medica
基金
国家自然科学基金项目(81260650)